India is witnessing a sharp rise in infectious diseases, with one in nine tests coming positive for dengue and influenza A, ...

Q VYJUVEK revenue and $623.2 million since U.S. launch VYJUVEK launched in Germany in 3Q; launched in France and Japan in ...

Current treatments for herpes simplex virus 1 (HSV-1) mainly target the viral DNA polymerase, but resistance is becoming an increasing problem. By understanding how HSV-1 initiates replication, ...

SHELTON, CONNECTICUT / ACCESS Newswire / October 29, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), announced that Nanoviricides CEO Dr Anil Diwan joined ...

SHELTON, CT / ACCESS Newswire / October 27, 2025 / NanoViricides, Inc. (NYSE American: NNVC ) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the ...

The new Learning Management System (LMS) will guide you through the entire Class 1 Learning Pathway. Track your progress, access course materials, and stay on top of your learning journey—all in one ...

MILWAUKEE -- The inevitability of the Dodgers is a concept their opponents would rather not consider. This year’s National League Championship Series pits the defending champs against a Brewers team ...

In 2025, most automakers are pretty much doing the same thing. Everybody builds crossovers, the majority of them have at least experimented with electrification, and, with exception only to the most ...

Clinical trials of conditional cytotoxic gene therapy of glioblastoma are now underway using retroviral and adenoviral vectors encoding herpes simplex virus 1 thymidine kinase (HSV-1-TK), followed by ...

TORONTO – Two nights after a 15-inning classic punched their ticket into the next round, the Mariners dug deep to find more late magic, shrugging off a cross-country flight and their weary bullpen to ...